Caribou Biosciences

+$0.67 (+3.34%) As of 4:07 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRBU and other ETFs, options, and stocks.

About CRBU

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology.

CEO
Rachel E. Haurwitz
Employees
67
Headquarters
Berkeley, California
Founded
2011

CRBU Key Statistics

Market Cap
1.24B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
520.66K
High Today
$20.91
Low Today
$20.04
Open Price
$20.50
Volume
181.74K
52 Week High
$32.65
52 Week Low
$15.00

CRBU Earnings

-$1.39
-$0.93
-$0.46
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure